Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys, Science, vol.353, pp.1129-1132, 2016. ,
Temporal dynamics of the primary human T cell response to yellow fever virus 17D as it matures from an effector-to a memory-type response, J. Immunol, vol.190, pp.2150-2158, 2013. ,
Anticipating the international spread of Zika virus from Brazil, Lancet, vol.387, pp.335-336, 2016. ,
Guillain-Barre Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study, Lancet, vol.387, pp.1531-1539, 2016. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01453407
Zika virus, French polynesia, South pacific, Emerg. Infect. Dis, vol.20, pp.1085-1086, 2013. ,
Structures of the zika virus envelope protein and its complex with a flavivirus broadly protective antibody, Cell Host Microbe, vol.19, pp.696-704, 2016. ,
, Zika Virus Vaccines: Challenges and Perspectives. Vaccines (Basel), vol.6, p.62, 2018.
Cross-reacting antibodies enhance dengue virus infection in humans, Science, vol.328, pp.745-748, 2010. ,
Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus, Nat. Immunol, vol.17, pp.1102-1108, 2016. ,
URL : https://hal.archives-ouvertes.fr/pasteur-02003950
Zika virus. II. Pathogenicity and physical properties, Trans. R. Soc. Trop. Med. Hyg, vol.46, pp.521-534, 1952. ,
, Science, vol.354, pp.237-240, 2016.
, Federated States OF Micronesia. N. Engl. J. Med, vol.360, pp.2536-2543, 2009.
Zika virus evolution on the edges of the Pacific ocean, Emerg. Microb. Infect, vol.6, p.111, 2017. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01680205
An update on Zika vaccine developments, Expert Rev. Vaccines, vol.16, pp.781-787, 2017. ,
Vaccination strategies against Zika virus, Curr Opin Virol, vol.23, pp.59-67, 2017. ,
Recent advances in zika virus vaccines, Viruses, vol.10, p.631, 2018. ,
Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine can, Lancet, vol.391, pp.552-562, 2018. ,
Fast Tracks and Roadblocks for Zika Vaccines, Vaccines (Basel), vol.6, p.77, 2018. ,
Pathogenic flaviviruses, Lancet, vol.371, pp.500-509, 2008. ,
Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus, Virology, vol.366, pp.349-360, 2007. ,
Zika virus is a global public health emergency, declares WHO, BMJ, vol.352, p.657, 2016. ,
Critique of World health organization recommendation of a dengue vaccine, J. Infect. Dis, vol.214, pp.1793-1795, 2016. ,
Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes, Lancet Infect. Dis, vol.10, pp.712-722, 2010. ,
Protective and immunological behavior of chimeric yellow fever dengue vaccine, Vaccine, vol.34, pp.1643-1647, 2016. ,
Zika virus-induced antibody response enhances dengue virus serotype 2 replication in vitro, J. Infect. Dis, vol.214, pp.1357-1360, 2016. ,
The early cellular signatures of protective immunity induced by live viral vaccination, Eur. J. Immunol, vol.42, pp.2363-2373, 2012. ,
Structure of the thermally stable Zika virus, Nature, vol.533, pp.425-428, 2016. ,
Full-length sequencing and genomic characterization of Bagaza, Kedougou, and Zika viruses, Arch. Virol, vol.152, pp.687-696, 2007. ,
Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, Emerg. Infect. Dis, vol.14, pp.1232-1239, 2007. ,
Vaccine protection against Zika virus from Brazil, Nature, vol.536, pp.474-478, 2016. ,
Altered glycosylation patterns increase immunogenicity of a subunit hepatitis C virus vaccine, inducing neutralizing antibodies which confer protection in mice, J. Virol, vol.90, pp.10486-10498, 2016. ,
Zika virus structural biology and progress in vaccine development, Biotechnol. Adv, vol.36, pp.47-53, 2018. ,
Flavivirus NS1 protein in infected host sera enhances viral acquisition by mosquitoes, Nature Microbiology, vol.1, p.16087, 2016. ,
Detection, characterization and quantitation of coxsackievirus A16 using polyclonal antibodies against recombinant capsid subunit proteins, J. Virol. Methods, vol.173, pp.115-120, 2011. ,
URL : https://hal.archives-ouvertes.fr/pasteur-00622889
Current Zika virus epidemiology and recent epidemics, Med. Maladies Infect, vol.44, pp.302-307, 2014. ,
Cultivation strategies to enhance productivity of Pichia pastoris: a review, Biotechnol. Adv, vol.33, pp.1177-1193, 2015. ,
, Lancet, vol.391, pp.563-571, 2018.
Antibody-dependent enhancement of infection and the pathogenesis of viral disease, Clin. Infect. Dis, vol.19, pp.500-512, 1994. ,
First experimental in vivo model of enhanced dengue disease severity through maternally acquired heterotypic dengue antibodies, PLoS Pathog, vol.10, p.1004031, 2014. ,
Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination, Nature, vol.543, pp.248-251, 2017. ,
Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: implications for vaccine development, Cell Host Microbe, vol.4, pp.229-238, 2008. ,
Insect cell-produced recombinant protein subunit vaccines protect against Zika virus infection, Antivir. Res, vol.154, pp.97-103, 2018. ,
Zika virus and birth defects -reviewing the evidence for causality, N. Engl. J. Med, vol.374, pp.1981-1987, 2016. ,
Flavivirus structural heterogeneity: implications for cell entry, Curr Opin Virol, vol.24, pp.132-139, 2017. ,
, Antiviral Research, vol.170, p.104578, 2019.
Modified mRNA vaccines protect against zika virus infection, Cell, vol.168, p.1110, 2017. ,
, Cell, vol.169, pp.597-609, 2017.
Immature dengue virus: a veiled pathogen, PLoS Pathog, vol.6, 2010. ,
Characterization of a novel murine model to study zika virus, Am. J. Trop. Med. Hyg, vol.94, pp.1362-1369, 2016. ,
Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice, Nature, vol.540, pp.443-447, 2016. ,
A live-attenuated Zika virus vaccine candidate induces sterilizing immunity in mouse models, Nat. Med, vol.23, pp.763-767, 2017. ,
The 3.8 A resolution cryo-EM structure of Zika virus, Science, vol.352, pp.467-470, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01439629
Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection, Science, vol.353, pp.823-826, 2016. ,
Type-and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopes, J. Virol, vol.81, pp.12816-12826, 2007. ,
Safety and immunogenicity of an anti-zika virus DNA vaccine -preliminary report, N. Engl. J. Med, 2017. ,
Molecular determinants of human neutralizing antibodies isolated from a patient infected with Zika virus, Sci. Transl. Med, vol.8, pp.369-179, 2016. ,
Highyield production of recombinant virus-like particles of enterovirus 71 in Pichia pastoris and their protective efficacy against oral viral challenge in mice, Vaccine, vol.33, pp.2335-2341, 2015. ,
Structural basis of zika virus-specific antibody protection, Cell, vol.166, pp.1016-1027, 2016. ,
Functional analysis of two cavities in flavivirus NS5 polymerase, J. Biol. Chem, vol.286, pp.14362-14372, 2011. ,